Johnson & Johnson head appointed the new chair of medical device sector

Latest News

The Medical Technology Association of Australia (MTAA) has announced Johnson & Johnson's Sue Martin has been appointed its new chair.

Mr Martin is the head of Johnson & Johnson MedTech Australia and New Zealand and succeeds Stryker's Maurice Ben-Mayor who has chaired the association for four years.

Mr Ben-Mayor said he was proud of the work MTAA has been able to achieve over the past four years.

“Thanks to the hard work of our members and, particularly our Board and committees, we were able to secure workable reforms to the Prostheses List, lead the industry’s step-up to support the government’s nationwide response to the pandemic by securing vital supplies and medical equipment, and work closely with the Therapeutic Goods Administration on regulatory reforms remaining strong advocates of fit-for-purpose policies.

“I’m excited to hand the baton over to Sue Martin as she takes our industry forward from strength to strength. Sue is a powerful voice for MedTech and thoughtful leader best suited to take the industry into its next chapter.”

Ms Martin has served on the MTAA board since 2019 and as its vice chair since 2019.

“I want to thank Maurice for his pragmatic, determined and engaging leadership of the industry and of MTAA’s Board. He has played an instrumental role in leading our industry through a tumultuous period in our history, and through the challenges and opportunities of ongoing reforms,” said Ms Martin.

“I’m looking forward to hitting the ground running as we drive forward with a number of vital strategic priorities for MTAA, determined by the Board, and developed by MTAA’s Public Affairs Committee (PAC), while I served as chair of the PAC.

“MTAA’s current industry-wide analysis being undertaken on the Value of MedTech, launching next year, and the more targeted report on opportunities for Australia through investment and adoption of a connected health future, are just two of immediate priorities that I look forward to delivering early next year.

“MTAA enjoys strong industry and medical partnerships that help us in supporting both innovative MedTech start-ups in Australia, access to new and better technologies, and promoting improved patient outcomes. Those serve as the basis of everything we do.”

MTAA CEO Ian Burgess thanked Mr Ben-Mayor for his service to the association and welcomed Ms Martin as the association's new chair.

“I am thrilled to have someone with Sue’s knowledge, expertise and dynamism stepping into the role of chair of MTAA’s Board. As a highly respected leader in our industry, Sue brings with her more than 20 years of experience, having worked across multiple countries and functions, spanning marketing and sales, to general management,” he said.

“As CEO, I’m looking forward to continuing to work closely with Sue to advance the strategic priorities of our industry and the Board’s vision for the future. I’d also like to take a moment to thank Maurice for his outstanding service to MTAA and the wider MedTech community.

“Maurice’s steadfastness and determined perseverance has seen MTAA, and MedTech in Australia, come out of some of the most challenging economic times we’ve seen in 100 years, a stronger voice to shape the direction of Australia’s health system for the betterment of patients.”